Loading...
Virtus LifeSci Biotech Clinical Trials ETF
BBC•AMEX
Financial ServicesAsset Management
$17.57
$-0.35(-1.98%)
Virtus LifeSci Biotech Clinical Trials ETF (BBC) Stock Overview
Explore Virtus LifeSci Biotech Clinical Trials ETF’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for BBCStats details for BBC are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for BBCAnalyst Recommendations details for BBC are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
Headquarters
DE
Founded
2014